Publications by authors named "Cosimo Martino"

Claim this Profile
L
Long-term Clinical Outcome of Trastuzumab and Lapatinib for HER2-positive Metastatic Colorectal Cancer.
Federica Tosi, Andrea Sartore-Bianchi, Sara Lonardi, Alessio Amatu, Francesco Leone, Cosimo Martino

Clin Colorectal Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pertuzumab and trastuzumab emtansine in patients with HER2-amplified metastatic colorectal cancer: the phase II HERACLES-B trial.
Andrea Sartore-Bianchi, Sara Lonardi, Cosimo Martino, Elisabetta Fenocchio, Federica Tosi

ESMO Open· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Central Nervous System as Possible Site of Relapse in ERBB2-Positive Metastatic Colorectal Cancer: Long-term Results of Treatment With Trastuzumab and Lapatinib.
Andrea Sartore-Bianchi, Sara Lonardi, Massimo Aglietta, Cosimo Martino, Fortunato Ciardiello

JAMA Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2 Positivity Predicts Unresponsiveness to EGFR-Targeted Treatment in Metastatic Colorectal Cancer.
Andrea Sartore-Bianchi, Alessio Amatu, Luca Porcu, Silvia Ghezzi, Sara Lonardi, Cosimo Martino

Oncologist· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiologic and Genomic Evolution of Individual Metastases during HER2 Blockade in Colorectal Cancer.
Giulia Siravegna, Luca Lazzari, Giovanni Crisafulli, Andrea Sartore-Bianchi, Benedetta Mussolin, Cosimo Martino

Cancer Cell· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial.
Andrea Sartore-Bianchi, Livio Trusolino, Cosimo Martino, Katia Bencardino, Sara Lonardi

Lancet Oncol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of a HER2 scoring system for colorectal cancer: results from a validation study.
Emanuele Valtorta, Cosimo Martino, Andrea Sartore-Bianchi, Frédérique Penaullt-Llorca, Giuseppe Viale

Mod Pathol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daily administration of low molecular weight heparin increases Hepatocyte Growth Factor serum levels in gynaecological patients: pharmacokinetic parameters and clinical implications.
Anna Surbone, Luca Fuso, Roberto Passera, Annamaria Ferrero, Cristiana Marchese, Cosimo Martino

BMC Res Notes· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cellular apoptosis susceptibility CAS/CSE1L gene protects ovarian cancer cells from death by suppressing RASSF1C.
Annalisa Lorenzato, Cosimo Martino, Nadia Dani, Yvonne Oligschläger, Anna Maria Ferrero

FASEB J· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fumarase tumor suppressor gene and MET oncogene cooperate in upholding transformation and tumorigenesis.
Barbara Costa, Daniela Dettori, Annalisa Lorenzato, Chiara Bardella, Nadia Coltella, Cosimo Martino

FASEB J· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis